N. Campillo

发表

ESICM LIVES 2016: part one

Hester F. Lingsma, A. M. Cavalheiro, H. S. King, 2016, Intensive Care Medicine Experimental.

Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates

A. Oliver, Ariadna Angulo-Brunet, S. Luque, 2021, Microbiology spectrum.

Pharmacokinetics and Pharmacodynamics of Meropenem by Extended or Continuous Infusion in Low Body Weight Critically Ill Patients

J. Carazo, S. Luque, N. Campillo, 2021, Antibiotics.

Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial

C. Vilaplana, W. Hope, V. Curull, 2020, Critical Care.

Comparison of Ceftolozane/Tazobactam Infusion Regimens in a Hollow-Fiber Infection Model against Extensively Drug-Resistant Pseudomonas aeruginosa Isolates

A. Oliver, S. Luque, N. Campillo, 2022, Microbiology spectrum.

Impact of ceftolozane/tazobactam concentrations in continuous infusion against extensively drug-resistant Pseudomonas aeruginosa isolates in a hollow-fiber infection model

A. Oliver, Ariadna Angulo-Brunet, S. Luque, 2021, Scientific Reports.

Dosage Individualization of Linezolid: Precision Dosing of Linezolid To Optimize Efficacy and Minimize Toxicity

M. Neely, W. Hope, R. Muñoz-Bermúdez, 2021, Antimicrobial Agents and Chemotherapy.

Colistin in the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: dose is critical.

J. Li, S. Luque, N. Campillo, 2019, The Journal of infection.

Plasma and peritoneal fluid population pharmacokinetics of micafungin in post-surgical patients with severe peritonitis.

W. Hope, J. Roberts, S. Luque, 2015, The Journal of antimicrobial chemotherapy.

Colistin for the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: a call for a dose update

J. Li, S. Luque, N. Campillo, 2020 .

Population Pharmacokinetics of Anidulafungin in Critically Ill Patients

W. Hope, R. Muñoz-Bermúdez, S. Luque, 2019, Antimicrobial Agents and Chemotherapy.

Urinary micafungin levels are sufficient to treat urinary tract infections caused by Candida spp.

S. Luque, N. Campillo, S. Grau, 2016, International journal of antimicrobial agents.

Urinary Concentrations of Colistimethate and Formed Colistin after Intravenous Administration in Patients with Multidrug-Resistant Gram-Negative Bacterial Infections

J. Li, S. Luque, N. Campillo, 2017, Antimicrobial Agents and Chemotherapy.

Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate.

S. Luque, N. Campillo, J. Horcajada, 2016, International journal of antimicrobial agents.

Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa: In Vivo and In Vitro Evidence

A. Oliver, S. Luque, N. Campillo, 2022, Antibiotics.

Plasma and cerebrospinal fluid concentrations of linezolid in neurosurgical critically ill patients with proven or suspected central nervous system infections.

J. Roberts, J. Lipman, J. Roberts, 2014, International journal of antimicrobial agents.

Efficacy of Ceftolozane-Tazobactam in Combination with Colistin against Extensively Drug-Resistant Pseudomonas aeruginosa, Including High-Risk Clones, in an In Vitro Pharmacodynamic Model

A. Oliver, Ariadna Angulo-Brunet, P. Ambrose, 2020, Antimicrobial Agents and Chemotherapy.

Colistin plus meropenem combination is synergistic in vitro against extensively drug-resistant Pseudomonas aeruginosa, including high-risk clones.

A. Oliver, P. Ambrose, S. Luque, 2019, Journal of global antimicrobial resistance.

Osteoarticular Cryptococcosis Successfully Treated with High-Dose Liposomal Amphotericin B Followed by Oral Fluconazole

E. Letang, N. Campillo, J. Horcajada, 2021, Infection and drug resistance.

Nebulized Micafungin Treatment for Scopulariopsis/Microascus Tracheobronchitis in Lung Transplant Recipients

N. Campillo, M. Deu, Ò. Len, 2021, Antimicrobial Agents and Chemotherapy.

Linezolid dosing in patients with liver cirrhosis: Standard dosing risks toxicity.

J. Roberts, R. Muñoz-Bermúdez, S. Luque, 2019, Therapeutic drug monitoring.

Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa

S. Luque, N. Campillo, J. Horcajada, 2017, BMC Infectious Diseases.

Systemic pharmacokinetics and safety of high doses of nebulized colistimethate sodium in critically ill patients with hospital-acquired and ventilator-associated pneumonia.

J. Carazo, S. Luque, N. Campillo, 2019, The Journal of antimicrobial chemotherapy.

Finding the Dose for Ceftolozane-Tazobactam in Critically Ill Children with and without Acute Kidney Injury

I. Trocóniz, M. J. Santiago, S. Fernández, 2020, Antibiotics.

Population pharmacokinetics of piperacillin in critically ill children including those undergoing continuous kidney replacement therapy.

I. Trocóniz, M. J. Santiago, S. Fernández, 2022, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Colistin Use in Patients with Chronic Kidney Disease: Are We Underdosing Patients?

S. Luque, N. Campillo, J. Horcajada, 2019, Molecules.

Urinary Concentrations of Colistimethate and Formed Colistin after Intravenous Administration in Patients with Multidrug-Resistant Gram-Negative Bacterial Infections

J. Li, S. Luque, N. Campillo, 2017, Antimicrobial Agents and Chemotherapy.